Ana-Iris Schiefer

13PUBLICATIONS
58CO-AUTHORS
Cellular immunologyMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 06, 2026
A single-cell atlas revealing cellular heterogeneity across healthy and diseased human thymus.

|Apr 02, 2025
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy.

Maša Zrimšek, Kristina Draganić, Anna Malzer

|Feb 23, 2025
Rare Lacrimal Gland Melanoma: A Case Report and Treatment Insights.

Reinhard Told, Ana-Iris Schiefer, Christoph Hoeller

|Jul 09, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Mathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl

|Jul 07, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

Barbara Peter, Gregor Eisenwort, Irina Sadovnik

|Jun 24, 2022
Tumour immune microenvironment in resected thymic carcinomas as a predictor of clinical outcome.

Giovanni Bocchialini, Ana-Iris Schiefer, Leonhard Müllauer

Pageof 3

Frequent Collaborators

5 joint publications

Bernhard Moser

4 joint publications

Hendrik Jan Ankersmit

3 joint publications

Peter Valent

3 joint publications

Stefan Janik